STICHTING UNITED PARENT PROJECTS MUSCULAR DYSTROPHY - Netherlands 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2016-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 6
As coordinator: 0
As participant: 6
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 2.747.621 0 1
2021 0 5.948.903 266.406 1
2020 0 6.666.325 165.688 1
2019 0 19.036.998 594.275 1
2018 0 1.921.963 182.513 1
2016 0 6.000.000 339.500 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
UNIVERSITY OF NEWCASTLE UPON TYNE3
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS2
JANSSEN PHARMACEUTICA NV2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN2
PFIZER LIMITED2
TAKEDA PHARMACEUTICALS INTERNATIONAL2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
ACADEMISCH ZIEKENHUIS GRONINGEN1
AKERSHUS UNIVERSITETSSYKEHUS HF1
ALLERGAN LIMITED1
ASSERTA GLOBAL HEALTHCARE SOLUTIONS1
ASSOCIACAO PROTECTORA DOS DIABETICOS DE PORTUGAL1
ASTELLAS PHARMA EUROPE BV1
ASTRAZENECA1
BAYER1
BIOMED CENTRAL LIMITED1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
CERATIUM LIMITED1
CHILDREN'S RESEARCH INSTITUTE1
CLICLAB TRANSFORMATIVE AGENT SL1
CONSORZIO FUTURO IN RICERCA1
COVANCE CLINICAL AND PERIAPPROVAL SERVICES1
DREEM1
ECHALLIANCE COMPANY LIMITED BY GUARANTEE1
ECLINICALHEALTH1
ECOLE NORMALE SUPERIEURE DE LYON1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK1
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH1
FAKULTNI NEMOCNICE V MOTOLE1
FEDERATION INTERNATIONALE DU DIABETE REGION EUROPE AISBL1
FH JOANNEUM GESELLSCHAFT MBH1
FONDAZIONE ITALIANA SCLEROSI MULTIPLA FISM ONLUS1
FORSCHUNGSINSTITUT FUR MOLEKULARE PATHOLOGIE GESELLSCHAFT MBH1
FUNDACIO INSTITUT UNIVERSITARI PERA LA RECERCA A L'ATENCIO PRIMARIA DE SALUT JORDI GOL I GURINA1
FUNDACIO SANT JOAN DE DEU1
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA1
FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL INFANTIL UNIVERSITARIO NINO JESUS1
FUNDACION PARA LA INVESTIGACION E INNOVACION BIOSANITARIA DE ATENCION PRIMARIA1
GREAT ORMOND STREET HOSPITAL FOR CHILDREN NHS FOUNDATION TRUST1
HEINRICHHEINEUNIVERSITAET DUESSELDORF1
IMAGINE INSTITUT DES MALADIES GENETIQUES NECKER ENFANTS MALADES FONDATION1
INNOVATION SPRINT1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
IQVIA RDS FRANCE1
JULIUS CLINICAL RESEARCH BV1
KAROLINSKA INSTITUTE1
KLINIKUM DER UNIVERSITAET ZU KOELN1
LEIDS UNIVERSITAIR MEDISCH CENTRUM1
LINK2TRIALS BV1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV1
MEDICAL RESEARCH NETWORK LIMITED1
MEDIDA SERVICOS EM MEDICINA EDUCACAO INVESTIGACAO DESENVOLVIMENTO E AVALIACAO1
MEDTRONIC INTERNATIONAL TRADING SARL1
MELANOMA PATIENT NETWORK EUROPE1
MONASH UNIVERSITY1
MSQUARED LASERS LIMITED1
MYSPHERA SL1
NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY1
NOVARTIS PHARMA1
NOVO NORDISK1
NV NEDERLANDSCH OCTROOIBUREAU1
OMADA INTERACTIVA SLL1
OPEN EVIDENCE1
OSPEDALE SAN RAFFAELE1
PEPGEN LIMITED1
PFIZER BV1
PLATEFORME EUROPEENNE DES FEMMES SCIENTIFIQUES AISBL1
PREDICTBY RESEARCH AND CONSULTING SL1
REGION HOVEDSTADEN1
REVERAGEN BIOPHARMA INC1
REVERAGEN BIOPHARMA LIMITED1
RIJKSUNIVERSITEIT GRONINGEN1
SANOFIAVENTIS1
SERVICIO MADRILENO DE SALUD1
SERVIER AFFAIRES MEDICALES1
SINGLE CELL DISCOVERIES BV1
STICHTING DUCHENNE DATA FOUNDATION1
STICHTING KEMPENHAEGHE1
STICHTING LYGATURE1
STICHTING MLC FOUNDATION1
STICHTING SANQUIN BLOEDVOORZIENING1
SYDDANSK UNIVERSITET1
SYNTHENA1
TAKEDA DEVELOPMENT CENTRE EUROPE1
TEVA PHARMACEUTICAL INDUSTRIES LIMITED1
THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN HEREINAFTER TRINITY COLLEGE DUBLIN1
THE SYNERGIST1
THE UNIVERSITY OF MANCHESTER1
TILBURG UNIVERSITY UNIVERSITEIT VAN TILBURG1
TRANSPHARMATION IRELAND1
UCB BIOPHARMA1
UDG ALLIANCE1
UNIVERSIDAD COMPLUTENSE DE MADRID1
UNIVERSIDAD POLITECNICA DE MADRID1
UNIVERSIDADE DO PORTO1
UNIVERSITA CATTOLICA DEL SACRO CUORE1
UNIVERSITA DEGLI STUDI DI FERRARA1
UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA1
UNIVERSITA VITASALUTE SAN RAFFAELE1

Constancy:

Total number of partners: 124
Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 121
Frequent / Rare Partner Ratio: 0.02

Project overview:

Start dateProjectacronymrolefundingpartners
2023-03-01Learning from animals how to regenerate: multidisciplinary training programme in regenerative biology REGENERATE-ITparticipant2.747.62128
2021-09-01BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe BEAMERparticipant5.948.90331
2020-01-01Brain Involvement iN Dystrophinopathies BINDparticipant6.666.32521
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99833
2018-01-01Social media platform dedicated to rare diseases, using collective intelligence for the generation of awareness and advanced knowledge on this large group of diseases. SHARE4RAREparticipant1.921.9639
2016-01-01VISION-DMD - Phase 2 Clinical Trials of VBP15: An Innovative Steroid-like Intervention on Duchenne Muscular Dystrophy VISION DMDparticipant6.000.0008